Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alia Fazza1, Sakina Chemil2, Sawssen Miladi1

  • 1Rheumatology department, Mongi Slim hospital, La Marsa, Tunisia, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.

La Tunisie Medicale
|February 19, 2024
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CEMIR Consensus guidelines among North Africa Rheumatologists for the use of Ultrasound in Rheumatoid Arthritis.

La Tunisie medicale·2026
Same author

Falls in rheumatoid arthritis: Prevalence and associated factors.

La Tunisie medicale·2026
Same author

Effect of Paracetamol on Blood Pressure: A Systematic Review.

La Tunisie medicale·2026
Same author

Effects of TNF-α Inhibitors on Subclinical Atherosclerosis and Endothelial Function in Patients with Psoriatic Arthritis: A Systematic Review.

La Tunisie medicale·2026
Same author

Effect of TNF alpha inhibitors on atherosclerosis in psoriatic arthritis patients: A Systematic Review Protocol.

La Tunisie medicale·2026
Same author

La Tunisie medicale·2026
Same journal

Abstracts International Scientific Day on Oxidative Stress, Aging, and Age-Related Diseases.

La Tunisie medicale·2026
Same journal

Pharmacological evaluation of anti-inflammatory potential and antispasmodic effect of aqueous extract from the brown seaweed, Cystoseira compressa.

La Tunisie medicale·2026
Same journal

Assessing the Accuracy of LDL-Cholesterol Estimation Formulas in the Tunisian Population.

La Tunisie medicale·2026
Same journal

Assessment of liver fibrosis in Chronic hepatitis B: performance of hematological parameters.

La Tunisie medicale·2026
Same journal

Association between Oxidative Stress, Cardiovascular Risk, and Disease Activity in Patients with Spondyloarthritis: A Cross-Sectional Study in a Tunisian Cohort.

La Tunisie medicale·2026
Same journal

Assessment of oral cancer awareness among dentists in Tunisia: A cross-sectional study.

La Tunisie medicale·2026
See all related articles

Juvenile idiopathic arthritis (JIA) management requires validated tools to assess disease activity and damage. This update reviews key outcome measures for optimizing care and improving quality of life for children with JIA.

Area of Science:

  • Pediatric Rheumatology
  • Clinical Assessment Tools
  • Chronic Childhood Illness

Background:

  • Juvenile idiopathic arthritis (JIA) is a chronic condition causing significant morbidity and impacting children's quality of life.
  • Effective management of JIA necessitates precise tools for assessing disease activity and damage.
  • Optimizing care for children with rheumatic diseases requires validated outcome measures.

Approach:

  • This update reviews the primary outcome measures currently employed in JIA patient care.
  • Focuses on instruments developed and validated through international collaborative efforts.
  • Highlights the importance of dedicated assessment tools for JIA.

Key Points:

  • Composite disease activity scores are crucial for monitoring JIA.

Related Experiment Videos

  • Measures of physical function and health-related quality of life are essential components.
  • Clinical damage assessment and Parent and Child Reported Outcomes (PCROs) provide comprehensive patient evaluation.

    • Conclusions:

    • Validated outcome measures are indispensable for optimizing JIA management.
    • A comprehensive approach utilizing various assessment tools ensures the best outcomes for children with JIA.
    • Continued development and application of these measures are vital for advancing pediatric rheumatology care.